These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 5086344)
21. Merging perspectives on drug value. Navarro RP Manag Care Interface; 1998 Jan; 11(1):53-4. PubMed ID: 10178971 [No Abstract] [Full Text] [Related]
22. Changes in drug utilization for seniors without prior prescription drug insurance. Hudson N Find Brief; 2009 Mar; 12(2):1-3. PubMed ID: 19297802 [TBL] [Abstract][Full Text] [Related]
23. Controlling pharmacy costs in the NC Medicaid program. Dobson LA N C Med J; 2003; 64(6):280-2. PubMed ID: 14983617 [No Abstract] [Full Text] [Related]
24. Working with PBMs (pharmacy benefit managers). Peterson C Healthplan; 1999; 40(2):83-6, 88-9. PubMed ID: 10537477 [No Abstract] [Full Text] [Related]
25. [Pharmaceutical economy and socialistic organization science. 23. Use of cybernetic information theory in the construction of an information system of the drug supply]. Böhm M Pharm Prax; 1971; 7():145-8. PubMed ID: 5092971 [No Abstract] [Full Text] [Related]
26. [Proposal of an information structure for uniform system of requirement inquiry and requirement control of drugs]. Schubert W Pharm Prax; 1971; 4():94-5. PubMed ID: 5577938 [No Abstract] [Full Text] [Related]
27. Plans should harness PBMs to help educate customers. Gibson T Manag Care; 2003 Mar; 12(3):8, 11. PubMed ID: 12685369 [No Abstract] [Full Text] [Related]
28. PBMs agree to disclose what they pay for drugs. Sipkoff M Manag Care; 2007 Nov; 16(11):19-20. PubMed ID: 18092549 [No Abstract] [Full Text] [Related]
29. The emerging specialty pharmaceutical market segment. Giaquinta D Manag Care Interface; 2003 Apr; 16(4):35-6. PubMed ID: 12747139 [No Abstract] [Full Text] [Related]
30. Mass customization--the next generation of pharmacy management. Chao S Am J Manag Care; 2003 Sep; Suppl Decison Maker News():5-7. PubMed ID: 14567452 [No Abstract] [Full Text] [Related]
31. [Contribution to pharmaceutical economy 13.: systematics and methodology of the pharmaceutic economy]. Seidlein HJ Pharm Prax; 1967 Aug; 8():211-6. PubMed ID: 5613503 [No Abstract] [Full Text] [Related]
32. [Significance of an active market image on the domestic drug market]. Voigt D Pharm Prax; 1972; 11():256-9. PubMed ID: 4649579 [No Abstract] [Full Text] [Related]
33. [Acceptance of medical technic in the task area of the pharmaceutical center of the district]. Kastens W; Martsch W Pharm Prax; 1971 Feb; 2():34-6. PubMed ID: 5575015 [No Abstract] [Full Text] [Related]
35. The potential for self-interested behavior by pharmaceutical manufacturers through vertical integration with pharmacy benefit managers: the need for a new regulatory approach. Mitchell EL Food Drug Law J; 1999; 54(1):151-83. PubMed ID: 11758556 [No Abstract] [Full Text] [Related]
36. By the Numbers. Prescription drugs and supplies. Mod Healthc; 2001 Dec; 31(52 Suppl):30. PubMed ID: 11808395 [No Abstract] [Full Text] [Related]
37. Too big? Caremark, AdvancePCS getting close look from feds. Becker C Mod Healthc; 2004 Jan; 34(2):14, 16. PubMed ID: 14959629 [No Abstract] [Full Text] [Related]
38. Rebates and spreads: pharmacy benefit management practices and corporate citizenship. Rentmeester CA; Garis RI J Health Polit Policy Law; 2008 Oct; 33(5):943-63; discussion 965-978. PubMed ID: 18818428 [TBL] [Abstract][Full Text] [Related]
39. Affordable prescription drugs for NC consumers: the next challenge. Savage HH N C Med J; 2003; 64(6):298-9. PubMed ID: 14983624 [No Abstract] [Full Text] [Related]
40. Think you can profit with drug risk? Think again! Capitation Manag Rep; 2000 Jan; 7(1):1-7. PubMed ID: 11183286 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]